Business   

GE Healthcare’s arm to scale up business

HYDERABAD: GE Healthcare’s life sciences business unit is targeting to scale up its revenue from sales by 40 per cent in the country by the end of this year. While its sales are now pegged at $18.5 million, the company proposes to increase it to $27 million by enhancing the sale of equipment to large biotech and pharma companies such as Biocon, Shantha and Biotechnic.

Anurag Gupta, Managing Director of GE Healthcare’s life sciences unit, who participated in the BioAsia-2008 here on Friday, said the company proposed to expand its research and development centre in Bangalore. The company had already set up a centre of excellence in Bangalore. The customer education centre and the existing R&D facility had 20 employees.

Mr. Gupta said that the company was looking at organic growth and was yet to decide on acquisitions. It is also making forays into cellular technologies to invent new methods of prediction, diagnosis and treatment of diseases.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Ultra Mega Power Projects face land crunch
Inflation rate crosses 4 per cent-mark
Caparo to build body structure for Tata Nano
IT, auto sectors get global recognition
Sensex suffers fresh losses
Rupee declines further
BHEL bags mega contract in U.P.
GE Healthcare’s arm to scale up business
Exchange Rates
Bullion Rates
Emaar MGF withdraws IPO
Reliance Power to trade in F&O segment
Govt. de-reserves 79 items
Cognizant forecasts $2.95b revenue in 2008
Usha Martin JV to produce oil tempered wires
Indo Tech commissions transformer unit
24x7 Software Tech unveils RecruitPro 360
ETA Star Appliances brings Italian brand
New CSO for Orchid Chemicals
Ramco wins HCM order from Landmark group

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu